PetMed Express reports Q3 net loss of $19K; revenue down 3% to $58.9M; declares $0.30 dividend

PETMED EXPRESS INC

2023-Q3 EPS reported $0.26 revenue$187,782,000

Net sales $58.9M (down 3% YoY); net loss $19K vs net income $4.3M prior year.
Adjusted diluted EPS $0.02; Adjusted EBITDA $2.7M, down 64% from $7.6M.
New customers increased 9% YoY, first increase in 10 quarters.
Board declares $0.30 per share quarterly dividend, payable Feb 27, 2023 to holders of record Feb 20.
Evaluating sales tax contingencies that could have material effect on results.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PETMED EXPRESS INC reported third quarter ended December 31, 2022 results: revenue $58.9 million, net income $19.0 thousand, EPS $(0.00) diluted earnings per share.

Period: third quarter ended December 31, 2022
Revenue: $58.9 million
Net income: $19.0 thousand
EPS: $(0.00) diluted earnings per share
Result: reported results

Exact text from the filing

Expert TM , today announced its financial results for its third quarter ended December 31, 2022. Quarterly Highlights • Net sales for the quarter ended December 31, 2022, were $58.9 million, compared to $60.7 million for third quarter in the prior year, a decrease of 3.0%. • PetMeds® reports new customers increased 9% year over year for the quarter ended December

View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-23-000011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.